This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Semprus BioSciences brings in $18mm through its Series B round
Semprus BioSciences Corp. has raised $18mm through the closing of its Series B venture round. SR One and Foundation Medical Partners co-led the financing (and will each contribute one board member) and were joined by existing investors 5AM Ventures and Pangaea Ventures. The company is developing the Semprus Sustain, which interrupts the way bacteria and blood interact with medical devices to prevent or at least limit complications due to infection and thrombus formation.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?